MedTrace Logo

The VaSecure BTK Study

NCT03638115 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2018-10-26

No results posted yet for this study

Summary

To assess the safety and performance of the VaSecure drug-coated PTA balloon catheter in the treatment of patients with Chronic Limb Threatening Ischemia (CLTI) of the lower limb below the knee (BTK)

Conditions

Interventions

DEVICE

VaSecure™

Drug Coated PTA Balloon Catheter

Sponsors & Collaborators

  • Novella Clinical

    collaborator OTHER

  • Vascuros Medical Pte Ltd

    lead INDUSTRY

Principal Investigators

  • Thomas Zeller, MD · Universitaets-Herzzentrum Freiburg - Bad Krozingen GmbH

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-30
Primary Completion
2019-06-01
Completion
2020-06-30

Countries

  • Belgium
  • Germany
  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03638115 on ClinicalTrials.gov